0001012975-24-000083.txt : 20240214 0001012975-24-000083.hdr.sgml : 20240214 20240214143326 ACCESSION NUMBER: 0001012975-24-000083 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 EFFECTIVENESS DATE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCH Venture Management, LLC CENTRAL INDEX KEY: 0001274403 ORGANIZATION NAME: IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19358 FILM NUMBER: 24636171 BUSINESS ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 FORMER COMPANY: FORMER CONFORMED NAME: ARCH VENTURE CORP DATE OF NAME CHANGE: 20031224 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001274403 XXXXXXXX 12-31-2023 12-31-2023 ARCH Venture Management, LLC
C/O ARCH VENTURE PARTNERS 8755 W. HIGGINS RD. #1025 CHICAGO IL 60631
13F HOLDINGS REPORT 028-19358 000158196 802-75688 N
Mark McDonnell Managing Director, CFO and CAO 773-380-6600 /s/ Mark McDonnell Chicago IL 02-14-2024 0 7 163507430 false
INFORMATION TABLE 2 ARCH.xml UNITY BIOTECHNOLOGY, INC. COM 91381U200 1939297 1004817 SH SOLE 0 0 1004817 DENALI THERAPEUTICS, INC. COM 24823R105 8181604 381249 SH SOLE 0 0 381249 GOSSAMER BIO, INC. COM 38341P102 7351023 8055916 SH SOLE 0 0 8055916 SINGULAR GENOMICS SYSTEMS, INC. COM 82933R100 1747886 3798926 SH SOLE 0 0 3798926 ERASCA, INC. COM 29479A108 23548330 11055554 SH SOLE 0 0 11055554 REVOLUTION MEDICINES, INC. COM 76155X100 92736493 3233490 SH SOLE 0 0 3233490 VERVE THERAPEUTICS, INC. COM 92539P101 28002797 2008809 SH SOLE 0 0 2008809